Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Popp

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacogenomics|August 29, 2003
High-speed genotyping of CYP1A2*1F mutation with fluorescent hybridization probes using the LightCyclerJohannes Popp, Barbara Messner, Werner Steimer
Pharmacogenomics|March 7, 2006
Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot studyJohannes Popp, Stefan Leucht, Stephan Heres, et al.
Nanophotonics (Berlin, Germany)|December 5, 2024
Theoretical model of passive mode-locking in terahertz quantum cascade lasers with distributed saturable absorbersLukas Seitner, Johannes Popp, Michael Haider, et al.
Physical Review Letters|February 9, 2024
Backscattering-Induced Dissipative Solitons in Ring Quantum Cascade LasersLukas Seitner, Johannes Popp, Ina Heckelmann, et al.
Clinical Chemistry|June 19, 2004
Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizersWerner Steimer, Konstanze Zöpf, Silvia von Amelunxen, et al.
Clinical Chemistry|December 14, 2004
Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapyWerner Steimer, Konstanze Zöpf, Silvia von Amelunxen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacogenomics|August 29, 2003
High-speed genotyping of CYP1A2*1F mutation with fluorescent hybridization probes using the LightCyclerJohannes Popp, Barbara Messner, Werner Steimer
Pharmacogenomics|March 7, 2006
Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot studyJohannes Popp, Stefan Leucht, Stephan Heres, et al.
Nanophotonics (Berlin, Germany)|December 5, 2024
Theoretical model of passive mode-locking in terahertz quantum cascade lasers with distributed saturable absorbersLukas Seitner, Johannes Popp, Michael Haider, et al.
Physical Review Letters|February 9, 2024
Backscattering-Induced Dissipative Solitons in Ring Quantum Cascade LasersLukas Seitner, Johannes Popp, Ina Heckelmann, et al.
Clinical Chemistry|June 19, 2004
Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizersWerner Steimer, Konstanze Zöpf, Silvia von Amelunxen, et al.
Clinical Chemistry|December 14, 2004
Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapyWerner Steimer, Konstanze Zöpf, Silvia von Amelunxen, et al.
Pageof 1